Cleared Traditional

K843440 - MINGO LOG 7

K843440 is an FDA 510(k) clearance for MINGO LOG 7, manufactured by Siemens Elema AB. The device is a Class 2 Toxicology device with product code DJH cleared through the Traditional 510(k) pathway .

K843440 · Siemens Elema AB · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1984
Decision
-
Days
Class 2
Risk

K843440 is an FDA 510(k) clearance for the MINGO LOG 7. Classified as Gas Chromatography, Phenobarbital (product code DJH), Class II - Special Controls.

Submitted by Siemens Elema AB (Chicago, US). The FDA issued a Cleared decision on September 4, 1984.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3660 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.

View all Siemens Elema AB devices

FDA 510(k) Submission Details - K843440

510(k) Number K843440 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 04, 1984
Decision Date September 04, 1984
Days to Decision -
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DJH Device Classification - Class 2, Special Controls

Product Code DJH Gas Chromatography, Phenobarbital
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3660
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.